DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Haemophilia B
Haemophilia B
MONONINE (“Difficulty ® Monoclonal Antibody Purified in Concentrating”; Subject Recovered)
Haematology: Non-Malignant
Autosomal Recessive Disorders and X Linked Disorders in Malaysia
Delivery of Treatment for Haemophilia
Gene Therapy: the Promise of a Permanent Cure
Guidelines for the Management of Haemophilia in Australia
Bluebird Bio, Inc. (Exact Name of Registrant As Specified in Its Charter)
Hemostasis: Definition
Gene Therapy
The Provision of Genetic Counselling Services for Haemophilia and Related Inherited Bleeding Conditions
Youth Perspectives on Genetic Inheritance, Carrier Status and Disclosure
Detection of Point Mutations in the Dystrophin Gene
Heterogeneity of the Factor IX Locus in Nine Hemophilia B Inhibitor Patients
Carrier Testing of Children for Two X Linked Diseases in a Family Based
Haemophilia B Curative FIX Production from a Low Dose UCOE-Based Lentiviral Vector Following Hepatic Pre-Natal Delivery
A Discrete Time Population Genetic Model for X-Linked Recessive Diseases
FRACP Lecture Series AGENDA Investigations Haemophilia
Gene Therapy
Top View
Bleeding Thrombotic and Platelet Disorder TIER1 Genes (V.ISTH 2019.1)
The Bleeding Child; Is It NAI? a E Thomas
Haemophilia As a PMB
Heritable Skewed X-Chromosome Inactivation Leads to Haemophilia a Expression in Heterozygous Females
Molecular Genetics of the Human X Chromosome KAY E DAVIES from the Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford OX3 9DU
DNA Markers and Duchenne Muscular Dystrophy
Promoterless Gene Targeting Without Nucleases Ameliorates Haemophilia B in Mice
Current Status of Haemophilia Gene Therapy
Understanding Haemophilia
Moderate Haemophilia B
Roche Enters Into Definitive Merger Agreement to Acquire Spark Therapeutics
Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects
Size of the Fragile X Premutation Is a Major Determinant of the Transition
The Clinical Use of Blood
Guidelines for the Emergency Treatment and Management of Patients with Haemophilia & Bleeding Disorders
How to Discuss Gene Therapy for Haemophilia? a Patient and Physician Perspective
Carriers of Haemophilia
Roche Enters Into Definitive Merger Agreement to Acquire Spark Therapeutics